What is gene therapy, what can it potentially treat, and what are its limitations? Is gene therapy currently being used in practice? Is gene therapy safe, and what are the risks involved? Where is the boundary between treatment and genetic enhancement? Can genetic doping exist, and what are the ethical boundaries that we should not cross?
Klára Grantz Šašková – an expert in biochemistry, working at the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and the Faculty of Science at Charles University, at the Department of Genetics and Microbiology. She leads a research group focused on DNA repair using proteins, studying hepatitis B virus, and nucleic acid delivery into cells using nanoparticles, which could accelerate vaccine development or improve the treatment of genetic diseases.
Radoslav Hajgajda – representative of the Association of Gene Therapy (ASGENT), a non-profit organization which mission is to connect the worlds of science, medicine, and patients.
Jan Procházka – a research scientist at the Institute of Molecular Genetics of the Czech Academy of Sciences, leading the phenotyping team of the Czech Centre for Phenogenomics, which focuses on genetics of rare inherited diseases and the possibilities of gene therapy development.
Duration: 75 minutes
Date: June 8, 2023, at 13:00
More information on the web: Veletrhu vědy.